Mitsubishi Chemical Group Confirms Q3 Figures After Audit as Profit Jumps on Portfolio Shift

Mitsubishi Chemical Holdings ( (JP:4188) ) has shared an update.

Mitsubishi Chemical Group said an independent auditor has completed an interim review of the Japanese originals of its condensed consolidated financial statements for the third quarter of the fiscal year ending March 31, 2026, with no changes required to the figures disclosed on February 5. The company reported nine‑month sales of ¥2.74 trillion, down 8.2% year on year, while core operating income slipped 2.4% but net income attributable to owners of the parent jumped 77.6%, reflecting the impact of discontinued operations after the transfer of Mitsubishi Tanabe Pharma and a resulting shift in its business portfolio.

Despite lower sales and operating income, basic earnings per share rose to ¥76.70 from ¥41.72, and equity attributable to owners increased, pushing the equity ratio up to 31.8%. The group kept its dividend policy unchanged, confirming an annual payout forecast of ¥32 per share for the fiscal year, signaling continued shareholder returns amid its ongoing portfolio restructuring and focus on core operations.

The most recent analyst rating on (JP:4188) stock is a Buy with a Yen1180.00 price target. To see the full list of analyst forecasts on Mitsubishi Chemical Holdings stock, see the JP:4188 Stock Forecast page.

More about Mitsubishi Chemical Holdings

Mitsubishi Chemical Group Corporation is a diversified chemicals manufacturer listed on the Tokyo Stock Exchange Prime Market. Operating under IFRS, it provides a broad range of chemical products and materials, and maintains a significant presence in global industrial and advanced materials markets.

Average Trading Volume: 5,526,293

Technical Sentiment Signal: Buy

Current Market Cap: Yen1443.7B

Find detailed analytics on 4188 stock on TipRanks’ Stock Analysis page.